News

Lilly to appeal as U.K. declines to endorse use of new Alzheimer’s drugs
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...
Bill Gates reveals 'next phase of Alzheimer's fight' as he shares dad's personal battle
Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in early diagnosis for the disease affecting millions.
Taiwan News5h
New Alzheimer’s drug to be administered in Taiwan
TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...
UK health service rejects costly, 'low benefit' Alzheimer's drugs
The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...
Family and friends shoulder the real cost of dementia: $224B in unpaid care
About 5.5 million Americans live with dementia, requiring US$53 billion in annual medical spending on doctor visits, ...
The Pharma Letter21h
BRIEF—NICE can’t justify cost to the NHS to approve Kisluna
The benefits from Eli Lilly’s Kisulna (donanemab) remain too small to justify the additional cost to the National Health Service (NHS), said the UK health technology assessor the National Institute ...